1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6096E40F1EDFAE3BA00258D30004BF112
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/096E40F1EDFAE3BA00258D30004BF112?OpenDocument
18
19OpenDocument
2018.97.14.83
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Analytics

Document Excerpt: Maximizing the Impact of Respiratory Analytics & Insights Teams: Delivering Value through Structure, Branding, and Innovation

DB Image

ID: MD-995


Features:

16 Info Graphics

19 Data Graphics

300+ Metrics

11 Narratives


Pages/Slides: 4


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5895 “Maximizing the Impact of Respiratory Analytics & Insights Teams: Delivering Value through Structure, Branding, and Innovation”.

Industries Profiled:
Pharmaceutical; Biotech; Research; Consulting; Diagnostic; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
AstraZeneca; Biotest AG; Boehringer Ingelheim; Grünenthal; Klosterfrau Healthcare Group; Lonza Inc.; MEDiSTRAVA; Qiagen; Sanofi; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.